Ondas Holdings Climbs 0.16% on $250M Volume Ranks 488th in U.S. Liquidity

. 17, 2025, , ranking 488th among U.S. equities by liquidity. The biotech firm’s moderate gain came amid mixed market conditions, though no material news directly linked to the stock’s performance was reported in the prior 72 hours.

Analysts noted limited catalysts for the price movement, as regulatory filings and clinical trial updates for ONDS’ pipeline remained unchanged from the previous quarter. , announced in late August, continue to be factored into valuation models but have not generated renewed momentum in the near term.

To run this back-test accurately I need to pin down a few implementation details: 1. Universe • Should I screen the entire U.S. listed equity universe (NYSE + NASDAQ + Amex), or only a subset such as the Russell 3000 or S&P 500 constituents? • Do you want to exclude ETFs, ADRs, closed-end funds, etc.? 2. , ? • Position sizing – Equal-weight each stock (i.e. ? . 3. , or would you like to apply commissions and a bid-ask spread estimate? 4. ? Once these parameters are fixed, I can generate the retrieval plan and run the back-test.